Related references
Note: Only part of the references are listed.Potential Anti-Atherosclerotic Effects of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus
Sandeep Dhindsa et al.
CURRENT DIABETES REPORTS (2014)
The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
Joshua I. Barzilay et al.
DIABETES CARE (2014)
Anti-inflammatory therapies for cardiovascular disease
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2014)
Targeting inflammation in the treatment of type 2 diabetes: time to start
Marc Y. Donath
NATURE REVIEWS DRUG DISCOVERY (2014)
Salicylate (Salsalate) in Patients With Type 2 Diabetes A Randomized Trial
Allison B. Goldfine et al.
ANNALS OF INTERNAL MEDICINE (2013)
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Hanford Yau et al.
CURRENT DIABETES REPORTS (2013)
Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
D. Di Raimondo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes
Ishwarlal Jialal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Share Paper
